Home › Funds › CPP Investments › SNDX
CPP Investments position in SNDX
SYNDAX PHARMACEUTICALS INC · Health Care
Latest position (Q1 2026)229.60K sh
Reported value held$5.36M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 70.00K | $1.35M | New |
| Q4 2024 | 70.00K | $925.40K | Hold |
| Q3 2025 | 229.60K | $3.53M | New |
| Q4 2025 | 229.60K | $4.82M | Hold |
| Q1 2026 | 229.60K | $5.36M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SNDX
- BlackRock Inc 9.02M sh · $197.18M · Q2 2026
- Vanguard Group 6.23M sh · $130.90M · Q4 2025
- Goldman Sachs Group 5.86M sh · $128.13M · Q2 2026
- Bank of America Corp 4.05M sh · $88.43M · Q2 2026
- Geode Capital Management 2.58M sh · $56.50M · Q2 2026
- Franklin Resources 2.29M sh · $49.98M · Q2 2026
- Millennium Management 2.05M sh · $44.90M · Q2 2026
- UBS Group AG 1.89M sh · $41.40M · Q2 2026
- Two Sigma Investments 1.58M sh · $34.50M · Q2 2026
- D. E. Shaw & Co 1.24M sh · $27.11M · Q2 2026
- BNY Mellon 1.04M sh · $22.74M · Q2 2026
- AQR Capital Management 853.30K sh · $18.65M · Q2 2026